Drug therapy for double-hit lymphoma
Double-hit lymphoma (DHL) is a rare type of aggressive B-cell lymphoma defined as a high-grade B-cell lymphoma (HGBCL) with the presence of MYC, BCL2 and/or BCL6 rearrangements. Patients usually present with rapidly progressive and advanced stage of disease and, commonly, with extranodal involvement...
Saved in:
Main Authors: | Vania Phuoc (Author), Jose Sandoval-Sus (Author), Julio C Chavez (Author) |
---|---|
Format: | Book |
Published: |
BioExcel Publishing Ltd,
2019-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cutaneous presentation of Double Hit Lymphoma
by: Yousef Khelfa MD, FACP, et al.
Published: (2016) -
Educational Case: Gastric High-Grade B-Cell Lymphoma With and Gene Rearrangement (Double-Hit Lymphoma)
by: Elham Vali Betts MD, et al.
Published: (2020) -
Prognostic impact of diffuse large B-cell lymphoma with extra copies of MYC, BCL2 and/or BCL6: comparison with double/triple hit lymphoma and double expressor lymphoma
by: Sixia Huang, et al.
Published: (2019) -
De novo double-hit B-cell precursor leukemia/lymphoma - an unusual presentation as peritoneal lymphomatosis
by: Balamurugan Thirunavukkarasu, et al.
Published: (2021) -
Decreased CD11c‐positive dendritic cells in the tumor microenvironment predict double‐hit/triple‐hit genotype and survival in diffuse large B‐cell lymphoma
by: Chang‐Tsu Yuan, et al.
Published: (2022)